Category Archives: Health

Latest From Health

8 Reasons New Medicines are Needed for Alzheimer’s

synthetic biology

Last week, the Alzheimer’s Association released an infographic with eight mythbusting facts to help dispel common misconceptions about the disease when it comes to prevention, financial impact, symptoms, and other areas. As the infographic confirms, there is no cure for this irreversible neurological disease, and only half of people living with Alzheimer’s (the 6th leading cause of death in the US) have actually been diagnosed. PhRMA’s report on Medicines in Development for Alzheimer’s Disease notes Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Bloomberg Caught Spreading Another Inaccurate “False Alarm” About Drug Prices

Greenwood_Jim_BTN

I was deeply disturbed by Bloomberg’s inaccurate report this morning that attempted to examine drug costs. The article claims it “decodes [our industry’s]…pricing practices.” But, in reality, it does no such thing. It fails to take in the full picture of biopharmaceutical successes and failures; admits its “proof” is merely guesstimates from an organization that wasn’t involved in pricing decisions; and in some cases, it just plain gets the facts wrong. First, this article myopically Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , ,

ICYMI: Gov. Tom Ridge, Tara O’Toole on Investing in Bioscience to Protect Against Bioterror

synthetic biology

Writing in the Pittsburgh Post-Gazette last week, Governor Tom Ridge and Tara O’Toole remind us that dangerous diseases are emerging more and more frequently, and that investment in bioscience is critical to fight these drug-resistant infections. When we cannot or fail to halt this spread, they create epidemics. This summer, the world is struggling to contain the spread of the Zika virus. Last fall, it was Ebola. Before that, it was MERS, SARS, avian flu. Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , ,

ICER’s Methodology Needs to Take Into Account Key Stakeholder Voices

new-bio-logo

Last week, the Institute for Clinical and Economic Review (ICER) released the scoping document for their pending review of therapies that treat non-small cell lung cancer (NSCLC).[1] The scoping document itself lays out the importance of these therapies given the realities of this deadly disease:[2] Lung cancer is the leading cause of cancer death in the U.S.[3] It is predicted to kill 158,000 Americans this year.[4] NSCLC makes up about 85 percent of lung cancers,[5] Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , ,

Stop Demeaning the Healthy Dialogue Between Doctors and Drug Companies

Greenwood_Jim_BTN

A recent report in The Wall Street Journal entitled, “Even Cheap Meals Influence Doctors’ Drug Prescriptions, Study Suggests,” attempts to suggest an untoward influence resulting from drug company-sponsored physician education events. After reading the full study, it is clear that the WSJ author not only misinterpreted the conclusions of the study, but completely discounts the role that companies have in educating physicians about their products. Contrary to the author’s point, communication between drug companies and Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , ,